SCHEMBL7879833

SCHEMBL7879833

CN(C(=N)N)C(=O)c1cc2c(C(F)(F)F)ccc(Oc3ccc(N)s3)c2[nH]1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7873318 0.88 PRSS1 (0.30)
SCHEMBL7879628 0.87 KDM4E (0.32) KDM4EHPGD
SCHEMBL7878061 0.87 NEK2 (0.32)
SCHEMBL7884335 0.87 ATM (0.34)
SCHEMBL7884656 0.86 SLC6A9 (0.33) KDM4EHPGD
SCHEMBL7873426 0.85 BRD4 (0.30)
SCHEMBL7880919 0.83 FFAR1 (0.36) KDM4EHPGD
SCHEMBL7881060 0.83 HRH3 (0.34)
SCHEMBL7884377 0.83 CYP1A2 (0.32) KDM4EHPGD
Hydrochloric Acid SCHEMBL7881490 0.83 FFAR1 (0.36) KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed